INO
Price
$2.79
Change
+$0.04 (+1.45%)
Updated
Sep 5, 04:59 PM (EDT)
Capitalization
148.27M
KROS
Price
$15.58
Change
+$0.03 (+0.19%)
Updated
Sep 5, 04:59 PM (EDT)
Capitalization
633.19M
54 days until earnings call
Interact to see
Advertisement

INO vs KROS

Header iconINO vs KROS Comparison
Open Charts INO vs KROSBanner chart's image
Inovio Pharmaceuticals
Price$2.79
Change+$0.04 (+1.45%)
Volume$17.23K
Capitalization148.27M
Keros Therapeutics
Price$15.58
Change+$0.03 (+0.19%)
Volume$9.1K
Capitalization633.19M
INO vs KROS Comparison Chart in %
Loading...
INO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KROS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INO vs. KROS commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INO is a Buy and KROS is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (INO: $2.75 vs. KROS: $15.55)
Brand notoriety: INO: Notable vs. KROS: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INO: 66% vs. KROS: 45%
Market capitalization -- INO: $148.27M vs. KROS: $633.19M
INO [@Biotechnology] is valued at $148.27M. KROS’s [@Biotechnology] market capitalization is $633.19M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INO’s FA Score shows that 0 FA rating(s) are green whileKROS’s FA Score has 1 green FA rating(s).

  • INO’s FA Score: 0 green, 5 red.
  • KROS’s FA Score: 1 green, 4 red.
According to our system of comparison, KROS is a better buy in the long-term than INO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INO’s TA Score shows that 5 TA indicator(s) are bullish while KROS’s TA Score has 6 bullish TA indicator(s).

  • INO’s TA Score: 5 bullish, 4 bearish.
  • KROS’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, KROS is a better buy in the short-term than INO.

Price Growth

INO (@Biotechnology) experienced а +11.79% price change this week, while KROS (@Biotechnology) price change was +1.97% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.44%. For the same industry, the average monthly price growth was +9.94%, and the average quarterly price growth was +31.78%.

Reported Earning Dates

KROS is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+2.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KROS($633M) has a higher market cap than INO($148M). INO YTD gains are higher at: 54.494 vs. KROS (-1.769). KROS has higher annual earnings (EBITDA): 25.5M vs. INO (-84.73M). KROS has more cash in the bank: 690M vs. INO (47.5M). INO has less debt than KROS: INO (10.7M) vs KROS (18M). KROS has higher revenues than INO: KROS (233M) vs INO (182K).
INOKROSINO / KROS
Capitalization148M633M23%
EBITDA-84.73M25.5M-332%
Gain YTD54.494-1.769-3,081%
P/E RatioN/A48.72-
Revenue182K233M0%
Total Cash47.5M690M7%
Total Debt10.7M18M59%
FUNDAMENTALS RATINGS
INO: Fundamental Ratings
INO
OUTLOOK RATING
1..100
31
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
INOKROS
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
79%
Momentum
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 3 days ago
79%
Declines
ODDS (%)
Bearish Trend 29 days ago
88%
Bearish Trend 8 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
82%
Aroon
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 3 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
INO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KROS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MSCGX11.830.15
+1.28%
Mercer US Small/Mid Cap Equity Y3
LMCLX9.270.09
+0.98%
Miller Income I
BRZAX13.170.10
+0.77%
BlackRock Sust Aware Adg Intl Eq Inv A
DEMRX26.320.18
+0.69%
Macquarie Emerging Markets R
RAZAX11.630.05
+0.43%
Russell Inv Multi-Asset Strat A

INO and

Correlation & Price change

A.I.dvisor indicates that over the last year, INO has been loosely correlated with KROS. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if INO jumps, then KROS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INO
1D Price
Change %
INO100%
+1.48%
KROS - INO
52%
Loosely correlated
-1.33%
RPTX - INO
51%
Loosely correlated
-1.74%
PCSA - INO
38%
Loosely correlated
-9.59%
OLMA - INO
35%
Loosely correlated
+0.95%
PGEN - INO
34%
Loosely correlated
-4.00%
More

KROS and

Correlation & Price change

A.I.dvisor indicates that over the last year, KROS has been loosely correlated with INO. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if KROS jumps, then INO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KROS
1D Price
Change %
KROS100%
-1.33%
INO - KROS
52%
Loosely correlated
+1.48%
ANAB - KROS
41%
Loosely correlated
-6.39%
DNLI - KROS
39%
Loosely correlated
-3.40%
XNCR - KROS
38%
Loosely correlated
+0.48%
ALT - KROS
38%
Loosely correlated
-3.26%
More